Viewing Study NCT07076212


Ignite Creation Date: 2025-12-26 @ 10:19 PM
Ignite Modification Date: 2025-12-31 @ 2:10 PM
Study NCT ID: NCT07076212
Status: RECRUITING
Last Update Posted: 2025-11-12
First Post: 2025-07-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluating NALIRIFOX vs Modified Gemcitabine, Nab-Paclitaxel and Cisplatin in Patients With Locally Advanced and Metastatic Pancreatic Adenocarcinoma
Sponsor: Medical University of South Carolina
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module